Literature DB >> 9739385

[Dosimetry of a blood irradiator].

L Bogner1, P Härtl, J Scherer, M Treutwein, M Herbst.   

Abstract

BACKGROUND: Blood and blood products are irradiated to avoid the graft-versus-host disease (GVHD) in immunosuppressed patients and to destroy tumor cells during the intra-operative autotransfusion in tumor surgery. For that purpose more and more dedicated gamma irradiators are used. In most cases the equipment is supplied with a dose calibration factor for a totally filled irradiation canister. As users handle different blood product volumes, it is necessary to investigate the influence of the irradiated blood volume on the absolute dose in a reference point and the dose distribution in the irradiation volume.
MATERIAL AND METHODS: The dose rate in the center of an empty irradiation canister of an IBL 437C blood irradiator (CIS Diagnostic) was investigated by means of Fricke solution dosimeters from the Physikalisch-Technische Bundesanstalt (PTB). Using thermoluminescence dosimetry (TLD) this value could be transferred to a situation with an empty or completely filled respectively with 2 blood samples (270 ml each) filled canister. Also essential for the irradiation of blood is the knowledge of the dose distribution in the irradiated volume. The distributions in the empty and the realistic filled canister were measured by positioning the TLD on the plexiglas holder in a regular pattern. The case of a completely filled container was investigated by means of the MR Fricke gel dosimetry. All distributions are presented as dose-volume-histograms (DVH).
RESULTS: The TLD-measurement in the center of the completely filled canister yielded a 4.8% higher dose rate value as compared to the suppliers certificate. From the investigations using the Fricke solution dosimeters in air combined with TLD-measurements values for the complete bandwidth of different container fillings could be derived. So the dose rate in the centre of the canister in the boundary conditions empty and full canister as compared to the values for the realistic filling condition (2 bags) are 117.5% and 94% respectively. Axial dose distributions and DVH have been determined for the 3 filling conditions.
CONCLUSIONS: We recommend a dose calibration measurement of a blood irradiator to determine the irradiation times for the chosen filling condition, which is typical for the hospital. The DVH presented in this work can be used to derive a value for the dose variance within the irradiated blood.

Entities:  

Mesh:

Year:  1998        PMID: 9739385     DOI: 10.1007/bf03038566

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  11 in total

1.  Pretransfusion blood irradiation: clinical rationale and dosimetric considerations.

Authors:  M E Masterson; R Febo
Journal:  Med Phys       Date:  1992 May-Jun       Impact factor: 4.071

Review 2.  Transfusion-associated graft-versus-host disease and blood irradiation.

Authors:  J V Linden; P T Pisciotto
Journal:  Transfus Med Rev       Date:  1992-04

3.  [The verification of optimized 3D-dosage distributions with an MR Fricke gel].

Authors:  J Scherer; L Bogner; M Herbst; A Müller-Broich
Journal:  Strahlenther Onkol       Date:  1997-01       Impact factor: 3.621

4.  [Prophylactic irradiation of blood components with conventional radiotherapy devices].

Authors:  I A Adamietz; R Müller; P Seidel; D Unverferth; R W Schulte; W Stangel; K Renner
Journal:  Strahlenther Onkol       Date:  1989-12       Impact factor: 3.621

5.  Third-party-mediated graft rejection and graft-versus-host disease after T-cell-depleted bone marrow transplantation, as demonstrated by hypervariable DNA probes and HLA-DR polymorphism.

Authors:  W Drobyski; S Thibodeau; R L Truitt; L A Baxter-Lowe; J Gorski; R Jenkins; J Gottschall; R C Ash
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

6.  [Graft vs host reaction (GvHR) following perinatal maternofetal transfusion or following blood cell substitution: the diagnostic value of HLA testing].

Authors:  S F Goldmann; W Ebell; R Blütters-Sawatzki; T Eiermann; W Kreth; A Wölpl; W Friedrich
Journal:  Beitr Infusionther Klin Ernahr       Date:  1987

Review 7.  Irradiation of blood products. Indications and guidelines.

Authors:  S F Leitman; P V Holland
Journal:  Transfusion       Date:  1985 Jul-Aug       Impact factor: 3.157

8.  Dose, dosimetry, and quality improvement of irradiated blood components.

Authors:  S F Leitman
Journal:  Transfusion       Date:  1993-06       Impact factor: 3.157

Review 9.  [Autologous blood transfusion in tumor operations].

Authors:  E Hansen; F Hofstädter; K Taeger
Journal:  Infusionsther Transfusionsmed       Date:  1994-10

10.  The effects of irradiation on blood components.

Authors:  L N Button; W C DeWolf; P E Newburger; M S Jacobson; S V Kevy
Journal:  Transfusion       Date:  1981 Jul-Aug       Impact factor: 3.157

View more
  1 in total

1.  Prevention of transfusion-associated graft-versus-host disease by irradiation: technical aspect of a new ferrous sulphate dosimetric system.

Authors:  Lucas Sacchini Del Lama; Evamberto Garcia de Góes; Paulo César Dias Petchevist; Edson Lara Moretto; José Carlos Borges; Dimas Tadeu Covas; Adelaide de Almeida
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.